Immunovia AB (publ)

IMMVF · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$25,050-$20,052-$18,906-$30,119
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$9,857$2,657-$6,676-$513
Other Non-Cash$13,487-$748$1,217$2,354
Operating Cash Flow-$16,108-$18,143-$24,365-$28,278
Investing Activities
PP&E Inv.-$5,559$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$4,956$0$0$0
Investing Cash Flow-$603$0$0$0
Financing Activities
Debt Repay.$2,012-$236-$570-$1,044
Stock Issued$0$10,249$37,473$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$12$0$0$0
Financing Cash Flow$2,024$10,013$36,903-$1,044
Forex Effect$19-$270-$187$436
Net Chg. in Cash-$265-$8,400$12,351-$28,886
Supplemental Information
Beg. Cash$3,079$37,669$25,318$54,204
End Cash$2,814$29,269$37,669$25,318
Free Cash Flow-$21,667-$18,143-$24,365-$28,278
Immunovia AB (publ) (IMMVF) Financial Statements & Key Stats | AlphaPilot